Proposed legislation would subject e-cigarettes to age verification law
New legislation proposed June 5 by Congresswoman Rosa DeLauro, D-Conn., would require Internet and mail order sellers of electronic cigarettes to verify a person’s age and identity before they deliver their products to a buyer’s door.
Early Screening for Lung Cancer? Many people are not aware you can be tested for the disease
Lung cancer is the second most common cancer in both men and women, and is by far the leading cause of cancer death. In 2017, the American Cancer Society estimates more than 200,000 new cases of lung cancer will be diagnosed in the United States, with more than 150,000 deaths. Lung cancer screening is now approved in the United States, and can help detect cancer early, when it is most curable. With November Lung Cancer Awareness Month, Lynn Tanoue, MD and Polly Sather, MSN, APRN, from the Lung Screening and Nodule Program at Yale Cancer Center, talk about lung cancer screening and why it can save lives.
New research alliance with pharma giant
Yale School of Medicine and the pharmaceutical company AstraZeneca (AZ) have embarked on a new collaboration, supported by AZ’s Oncology Global Medical Affairs group, that aims to speed translational and clinical research to develop lifesaving, next-generation therapies for lung and other cancers.Source: Medicine@Yale
Precision Medicine: Custom Treatment From Your Genes
In 2001, we thought it was a remarkable accomplishment to sequence an entire human genome and do that once. Today, we're doing this thousands of times a day around the world. These lead to not just new diagnoses, but also can lead to new therapies that might not have been thought of previously.Source: WebMD
Yale Cancer Center receives $11 million from National Cancer Institute for lung cancer research
Armed with an $11 million grant from the National Cancer Institute (NCI), Yale Cancer Center and Smilow Cancer Hospital at Yale-New Haven will launch a new research program in non-small cell lung cancer, one of the world’s most prevalent and lethal forms of cancer.
How the Lung-MAP Clinical Trial is Responding to Rapidly Changing Science
When the Lung Master Protocol clinical trial (Lung-MAP or S1400) (1) was launched in June 2014, the goal of this first-of-its kind trial was simple: find effective treatments for seriously ill patients suffering from a specific type of lung cancer. Lung-MAP is unique—a biomarker driven, multi-drug, multi-arm, study design, using a targeted screening approach, with state-of-the-art genomic profiling of neoplastic cells to match patients with sub-studies testing investigational new drugs and immuSource: The Cancer Letter
Winchester Center for Lung Disease is Flourishing Since Opening in 2021
The Winchester Center for Lung Disease (WCLD) opened in March 2021 at the North Haven Medical Center to improve access to exceptional care for more people with lung conditions. The expanded facilities at the Winchester Center have allowed expansion of subspecialized pulmonary care as well as access to a wide array of multidisciplinary services, more than what was possible at the original Winchester Chest Clinic (WCC) on Yale New Haven Hospital’s York Street Campus.
Dr. Kyle Bramley Leads Interventional Pulmonary Program
The Yale Interventional Pulmonary team in Yale’s Section of Pulmonary, Critical Care, and Sleep Medicine (Yale-PCCSM) employs advanced technologies to diagnose and treat diseases in the chest, such as lung nodules and masses, lymph node enlargement, complex airways, and pleural effusions. The program, led by Kyle Bramley, MD, assistant professor of medicine (pulmonary), was one of the first interventional pulmonology programs in Connecticut when it was established in 2009. Today it remains the largest interventional pulmonary service in the state.
Assessing Symptoms in Older Adults After Critical Illness
Older adults who survive a critical illness, such as sepsis or respiratory failure, often have symptoms that restrict activities, but little is known about how these symptoms change over time or compare with those prior to illness, and whether these changes differ among vulnerable subgroups. In a new study, Yale researchers evaluated changes in restricting symptoms among adults aged 70 or older during the six months after discharge from the ICU or intensive care unit.
Preventing Worsening Asthma in Inner-city Patients
A new perspective published in the Annals of Allergy, Asthma, and Immunology sheds light on strategies to prevent asthma exacerbations in inner-city patients. Previous research has demonstrated that living in an inner-city is an independent risk factor for Emergency Department visits and hospitalizations from asthma.
Introducing the Internal Medicine 2021-2022 Annual Report
In the new report, there are updates from our clinical programs, research endeavors, our work on diversity, equity, and inclusion, and educational programs. Our faculty members were honored for their educational excellence. Research initiatives at Yale received applause on the national and international stages. This book highlights all that we have accomplished together this past year…
Ferrante Receives R01 Grant for Geriatric Critical Care Research
Lauren Ferrante, MD, MHS, assistant professor of medicine (pulmonary, critical care and sleep medicine), was awarded a Research Project Grant (R01) from the National Institutes of Health (NIH) for the project Evaluating the Unmet Needs of Older Adults to Promote Functional Recovery After a Critical Illness (LANTERN).
Americans Have Breathed More Wildfire Smoke in Eight Months Than in Entire Years
Wildfire smoke contains tiny particles that can travel deep into the body and wreak havoc, particularly on the respiratory and cardiac systems, says Carrie Redlich, a pulmonologist and occupational environmental medicine physician at the Yale School of Medicine, who wasn’t involved in the exposure analysis. There’s still a lot that doctors don’t know about the impacts of wildfire smoke, however. Much of the research is based on general air pollution, and it’s difficult to tease apart the role smoke played in any given health outcome, Redlich says.Source: Scientific American